Summary
An increased frequency of kidney stone formation is reported in patients with inflammatory bowel disease. In order to investigate its pathogenesis, the concentrations of factors known to enhance calcium oxalate stone formation (oxalate, calcium, uric acid) as well as of inhibitory factors for nephrolithiasis (magnesium, citrate) were determined in the urine of 86 patients with Crohn's disease and compared with those of 53 metabolically healthy controls. Six patients with Crohn's disease already had experienced calcium oxalate nephrolithiasis. Patients with Crohn's disease had significantly higher urinary oxalate and lower magnesium and citrate concentrations. Among all patients magnesium and citrate were significantly lower in those with a positive history of kidney stones. Our results demonstrate that the increased propensity for renal stone formation in patients with Crohn's disease is a result not only of increased urinary oxalate, but also of decreased urinary magnesium and citrate concentrations.
Similar content being viewed by others
Abbreviations
- CDAI:
-
Crohn's disease activity index
References
Andersson H, Bosaeus I, Fasth S, Hellberg R, Hulten L (1987) Cholelithiasis and urolithiasis in Crohn's disease. Scand J Gastroenterol 22:253–256
Best WR, Becktel JM, Singleton JW, Kern F (1976) Development of a Crohn's disease activity index. Gastroenterology 70:439–444
Clayman RV, Buchwald H, Varco RL, DeWolf WC, Williams RD (1978) Urolithiasis in patients with jejunoileal bypass. Surg Gynecol Obstet 147:225–230
Earnest DL, Johnson G, Williams HE (1974) Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology 66:1114–1122
Fried R, Fried LW (1970) Xanthin. Methoden der enzymatischen Analyse. In: Bergmeyer H (ed) Verlag Chemie, Weinheim, S 1879
Gelzayd EA, Breuer RI, Kirsner JB (1968) Nephrolithiasis in inflammatory bowel disease. Am J Dig Dis 13:1027–1034
Hammarsten G (1936) Eine experimentelle Studie über Calciumoxalat als Steinbildner in den Harnwegen: Speziell mit Rücksicht auf die Bedeutung des Magnesiums. Harasowitz, Leipzig, S 1–155
Kalistratos G (1974) Die Bedeutung des Aussalzeffektes für die Harnsteinentstehung,-prophylaxe und -therapie. Fortschr Urol Nephrol 4:56–59
King JS, O'Connor FJ, Smith MJ, Crouse L (1968) The urinary calcium/magnesium ratio in calciferous stone formers. Invest Urol 6:60–66
Kyle J (1980) Urinary complications of Crohn's disease. World J Surg 4:153–160
Lescovar R, Hartung R, Kratzer M (1980) Bedeutung von Kristallisationsinhibitoren bei der Kalziumlithiasis. Krankenhausarzt 53:875–879
Mandell J, Kraus E, Millian JC (1980) Oxalate induced acute renal failure in Crohn's disease. Am J Med 69:628–632
Marangella M, Maddalena D, Futtero B, Bruno M, Malfi B, Linari F (1979) Hiperossaluria nella calcolosi renale e nel morbo di Crohn. Minerva Nefrologica 26:543–548
Marshall RW, Robertson WG (1976) Nomogram for the estimation of saturation of urine with calciumoxalate, calciumphosphate, magnesium ammoniumphosphate, uric acid, sodium acid urate, ammonium acid urate and cystine. Clin Chim Acta 72:253–260
Meyer JL (1974) Formation constants for interaction of citrate with calcium and magnesium ions. Anal Biochem 62:295–300
Möllering H, Gruber W (1966) Determination of citrate with citrate lyase. Anal Biochem 17:369–376
Nyhlin H, Dyckner T, Ek B, Westner PO (1982) Magnesium in Crohn's disease. Acta Med Scand [Suppl] 661:21–25
Oreopoulos DG, Soyannwo M, McGeown M (1968) Magnesium/calcium ratio in urine of patients with renal stones. Lancet II:410–412
Rudman D, Dedonis JL, Fountain MT, Chandler JB, Gerron G (1980) Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med 303:657–661
Saegesser F (1980) Urinary complications of Crohn's disease: invited commentary. World J Surg 4:159
Schmidt K, Hagmaier V, Bruchelt G, Rutishauser G (1980) Analytical isotachophoresis: a rapid and sensitive method for determination of urinary oxalate. Urological Res 8:177–180
Schofield PF, Staff WG, Moore T (1968) Uretral involvement in regional ileitis (Crohn's disease). J Urol 99:412–415
Smith LH, Fromm H, Hofmann AF (1972) Acquired hyperoxaluria, nephrolithiasis and intestinal disease, description of a syndrome. N Engl J Med 286:1371–1375
Terhost B, Melchior H (1972) Die medikamentöse Behandlung des Harnsteinleidens. II. Periorale Litholyse und Prophylaxe. Uro Int 27:230–236
Thiele H, Lampe HJ, Trede M, Ludwig G (1980) Urologische Komplikationen bei Morbus Crohn. Chirurg 51:150–154
Valensieck W, Hesse A, Bach D (1981) Inzidenz and Prävalenz und Morbidität des Harnsteinleidens in der BRD. Fortschr Urol Nephrol 17:1–5
Welshman SG, McGeown MG (1976) Urinary citrate excretion in stone-formers and normal controls. Br J Urol 48:7–11
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. N. Zöllner on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Böhles, H., Beifuss, O.J., Brandl, U. et al. Urinary factors of kidney stone formation in patients with Crohn's disease. Klin Wochenschr 66, 87–91 (1988). https://doi.org/10.1007/BF01774220
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01774220